Ghent University Academic Bibliography

Advanced

Development and implementation of guidelines in allergic rhinitis: an ARIA-GA2LEN paper

J Bousquet, HJ Schunemann, T Zuberbier, Claus Bachert UGent, CE Baena-Cagnani, PJ Bousquet, J Brozek, GW Canonica, TB Casale and P Demoly, et al. (2010) ALLERGY. 65(10). p.1212-1221
abstract
The links between asthma and rhinitis are well characterized. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines stress the importance of these links and provide guidance for their prevention and treatment. Despite effective treatments being available, too few patients receive appropriate medical care for both diseases. Most patients with rhinitis and asthma consult primary care physicians and therefore these physicians are encouraged to understand and use ARIA guidelines. Patients should also be informed about these guidelines to raise their awareness of optimal care and increase control of the two related diseases. To apply these guidelines, clinicians and patients need to understand how and why the recommendations were made. The goal of the ARIA guidelines is to provide recommendations about the best management options for most patients in most situations. These recommendations should be based on the best available evidence. Making recommendations requires the assessment of the quality of available evidence, deciding on the balance between benefits and downsides, consideration of patients' values and preferences, and, if applicable, resource implications. Guidelines must be updated as new management options become available or important new evidence emerges. Transparent reporting of guidelines facilitates understanding and acceptance, but implementation strategies need to be improved.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
CONTROLLED-TRIAL, SEVERE ASTHMA, NONALLERGIC RHINITIS, RANDOMIZED-TRIALS, CONSORT STATEMENT, PRIMARY-CARE, 2008 UPDATE, RECOMMENDATIONS, MANAGEMENT, QUALITY, ARIA, asthma, EAACI, EFA, GA2LEN, IPCRG, rhinitis
journal title
ALLERGY
Allergy
volume
65
issue
10
pages
1212 - 1221
Web of Science type
Article
Web of Science id
000281631500002
JCR category
ALLERGY
JCR impact factor
6.297 (2010)
JCR rank
2/20 (2010)
JCR quartile
1 (2010)
ISSN
0105-4538
DOI
10.1111/j.1398-9995.2010.02439.x
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1241772
handle
http://hdl.handle.net/1854/LU-1241772
date created
2011-05-25 14:43:55
date last changed
2011-06-01 13:17:25
@article{1241772,
  abstract     = {The links between asthma and rhinitis are well characterized. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines stress the importance of these links and provide guidance for their prevention and treatment. Despite effective treatments being available, too few patients receive appropriate medical care for both diseases. Most patients with rhinitis and asthma consult primary care physicians and therefore these physicians are encouraged to understand and use ARIA guidelines. Patients should also be informed about these guidelines to raise their awareness of optimal care and increase control of the two related diseases. To apply these guidelines, clinicians and patients need to understand how and why the recommendations were made. The goal of the ARIA guidelines is to provide recommendations about the best management options for most patients in most situations. These recommendations should be based on the best available evidence. Making recommendations requires the assessment of the quality of available evidence, deciding on the balance between benefits and downsides, consideration of patients' values and preferences, and, if applicable, resource implications. Guidelines must be updated as new management options become available or important new evidence emerges. Transparent reporting of guidelines facilitates understanding and acceptance, but implementation strategies need to be improved.},
  author       = {Bousquet, J and Schunemann, HJ and Zuberbier, T and Bachert, Claus and Baena-Cagnani, CE and Bousquet, PJ and Brozek, J and Canonica, GW and Casale, TB and Demoly, P and Gerth van Wijk, R and Ohta, K and Bateman, ED and Calderon, M and Cruz, AA and Dolen, WK and Haughney, J and Lockey, RF and Lotvall, J and O'Byrne, P and Spranger, O and Togias, A and Bonini, S and Boulet, LP and Camargos, P and Carlsen, KH and Chavannes, NH and Delgado, L and Durham, SR and Fokkens, WJ and Fonseca, J and Haahtela, T and Kalayci, O and Kowalski, ML and Larenas-Linnemann, D and Li, J and Mohammad, Y and Mullol, J and Naclerio, R and O'Hehir, RE and Papadopoulos, N and Passalacqua, G and Rabe, KF and Pawankar, R and Ryan, D and Samolinski, B and Simons, FER and Valovirta, E and Yorgancioglu, A and Yusuf, OM and Agache, I and Ait-Khaled, N and Annesi-Maesano, I and Beghe, B and Ben Kheder, A and Blaiss, MS and Boakye, DA and Bouchard, J and Burney, PG and Busse, WW and Chan-Yeung, M and Chen, Y and Chuchalin, AG and Costa, DJ and Custovic, A and Dahl, R and Denburg, J and Douagui, H and Emuzyte, R and Grouse, L and Humbert, M and Jackson, C and Johnston, SL and Kaliner, MA and Keith, PK and Kim, YY and Klossek, JM and Kuna, P and Le, LT and Lemiere, C and Lipworth, B and Mahboub, B and Malo, JL and Marshall, GD and Mavale-Manuel, S and Meltzer, EO and Morais-Almeida, M and Motala, C and Naspitz, C and Nekam, K and Niggemann, B and Nizankowska-Mogilnicka, E and Okamoto, Y and Orru, MP and Ouedraogo, S and Palkonen, S and Popov, TA and Price, D and Rosado-Pinto, J and Scadding, GK and Sooronbaev, TM and Stoloff, SW and Toskala, E and Van Cauwenberge, Paul and Vandenplas, O and van Weel, C and Viegi, G and Virchow, JC and Wang, DY and Wickman, M and Williams, D and Yawn, BP and Zar, HJ and Zernotti, M and Zhong, N},
  issn         = {0105-4538},
  journal      = {ALLERGY},
  keyword      = {CONTROLLED-TRIAL,SEVERE ASTHMA,NONALLERGIC RHINITIS,RANDOMIZED-TRIALS,CONSORT STATEMENT,PRIMARY-CARE,2008 UPDATE,RECOMMENDATIONS,MANAGEMENT,QUALITY,ARIA,asthma,EAACI,EFA,GA2LEN,IPCRG,rhinitis},
  language     = {eng},
  number       = {10},
  pages        = {1212--1221},
  title        = {Development and implementation of guidelines in allergic rhinitis: an ARIA-GA2LEN paper},
  url          = {http://dx.doi.org/10.1111/j.1398-9995.2010.02439.x},
  volume       = {65},
  year         = {2010},
}

Chicago
Bousquet, J, HJ Schunemann, T Zuberbier, Claus Bachert, CE Baena-Cagnani, PJ Bousquet, J Brozek, et al. 2010. “Development and Implementation of Guidelines in Allergic Rhinitis: An ARIA-GA2LEN Paper.” Allergy 65 (10): 1212–1221.
APA
Bousquet, J, Schunemann, H., Zuberbier, T., Bachert, C., Baena-Cagnani, C., Bousquet, P., Brozek, J., et al. (2010). Development and implementation of guidelines in allergic rhinitis: an ARIA-GA2LEN paper. ALLERGY, 65(10), 1212–1221.
Vancouver
1.
Bousquet J, Schunemann H, Zuberbier T, Bachert C, Baena-Cagnani C, Bousquet P, et al. Development and implementation of guidelines in allergic rhinitis: an ARIA-GA2LEN paper. ALLERGY. 2010;65(10):1212–21.
MLA
Bousquet, J, HJ Schunemann, T Zuberbier, et al. “Development and Implementation of Guidelines in Allergic Rhinitis: An ARIA-GA2LEN Paper.” ALLERGY 65.10 (2010): 1212–1221. Print.